Vertex Pharmaceuticals, Inc. (VRTX)
454.68
-5.91
(-1.28%)
USD |
NASDAQ |
Jan 13, 16:00
454.56
-0.12
(-0.03%)
After-Hours: 17:13
Vertex Pharmaceuticals Market Cap: 115.36B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 142.85B |
| Amgen, Inc. | 174.71B |
| Eli Lilly & Co. | 963.90B |
| Merck & Co., Inc. | 268.70B |
| Regeneron Pharmaceuticals, Inc. | 79.74B |
Market Cap Related Metrics
| PE Ratio | 32.04 |
| PS Ratio | 10.04 |
| Price to Book Value | 6.661 |
| Price to Free Cash Flow | 35.30 |
| Price | 454.68 |
| Earnings Yield | 3.12% |
| Operating PE Ratio | 26.02 |
| Normalized PE Ratio | 29.06 |